Trinity Biotech (TRIB) EPS (Diluted) Growth (3y) (2012 - 2024)
Trinity Biotech (TRIB) EPS (Diluted) Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -12.16% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 19.81% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 50.83% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -6.12% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 33.46% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 11.48% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 1,810.75% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 18.07% |
| 10 | Trinity Biotech | 6.46 Mn | 1.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -151.52% |
| Sep 30, 2024 | -56.88% |
| Jun 30, 2024 | 3.60% |
| Mar 31, 2024 | -48.44% |
| Dec 31, 2023 | -14.57% |
| Sep 30, 2023 | -38.04% |
| Jun 30, 2023 | 50.83% |
| Mar 31, 2023 | -20.39% |
| Dec 31, 2022 | -24,473.07% |
| Sep 30, 2022 | -522.41% |
| Jun 30, 2022 | 31.38% |
| Mar 31, 2022 | -292.15% |
| Dec 31, 2021 | -10,919.25% |
| Sep 30, 2021 | 12.86% |
| Jun 30, 2021 | -32.25% |
| Mar 31, 2021 | 59.70% |
| Dec 31, 2020 | -18,483.05% |
| Sep 30, 2020 | 156.65% |
| Jun 30, 2020 | -54.67% |
| Mar 31, 2020 | -57.62% |